Dudley, Mark E <br/><br/>
Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens.  [electronic resource] 

 -  Journal of clinical oncology : official journal of the American Society of Clinical Oncology  Nov 2008 
 - 5233-9 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1527-7755 
<br/><br/><label>Standard No.: </label>10.1200/JCO.2008.16.5449  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adolescent<br/>Adoptive Transfer<br/>Adult<br/>Aged<br/>Antineoplastic Agents--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--adverse effects<br/>Cells, Cultured<br/>Chemotherapy, Adjuvant<br/>Child<br/>Cyclophosphamide--administration & dosage<br/>Female<br/>Humans<br/>Interleukin-15--blood<br/>Interleukin-2--therapeutic use<br/>Interleukin-7--blood<br/>Kaplan-Meier Estimate<br/>Lymphocyte Depletion<br/>Lymphocytes, Tumor-Infiltrating--immunology<br/>Male<br/>Melanoma--drug therapy<br/>Middle Aged<br/>Myeloablative Agonists--administration & dosage<br/>Neoadjuvant Therapy<br/>Neoplasm Metastasis<br/>Pilot Projects<br/>Radiotherapy Dosage<br/>Radiotherapy, Adjuvant<br/>Time Factors<br/>Treatment Outcome<br/>Vidarabine--administration & dosage